Christopher Mason - Jun 10, 2021 Form 4 Insider Report for AVROBIO, Inc. (AVRO)

Role
Chief Scientific Officer
Signature
/s/ Christopher Gerry, Attorney in Fact for Christopher Mason
Stock symbol
AVRO
Transactions as of
Jun 10, 2021
Transactions value $
$0
Form type
4
Date filed
6/14/2021, 06:03 PM
Next filing
Jul 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +125K $0.00 125K Jun 10, 2021 Common Stock 125K $9.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares shall vest and become exercisable on June 10, 2023, and the remaining 50% shall vest and become exercisable on June 10, 2024.